Moderna (MRNA) Rule 144 notice: 53,336 shares proposed via Fidelity on 05/15/2026

Rhea-AI Filing Summary

Moderna, Inc. filing a Rule 144 notice regarding the proposed sale of 53,336 shares of Common Stock through Fidelity Brokerage Services on 05/15/2026. The excerpt also records a prior sale by Stephen Hoge of 160,009 shares on 02/23/2026, with cash considerations shown.

Insights

Securities Counsel

Rule 144 notice of resale by an affiliate or control person; procedural disclosure.

The filing lists a proposed sale of 53,336 shares via Fidelity Brokerage Services on 05/15/2026 under Rule 144 mechanics. The entry includes a cash amount of $2,581,462.40, suggesting an expected gross value associated with that lot.

Prior activity by Stephen Hoge shows a sale of 160,009 shares on 02/23/2026 with proceeds of $7,814,839.56. These are disclosure items that notify the market of planned or recent resale activity; timing and final execution remain subject to broker routing and Rule 144 conditions.

Equity Markets Analyst

Resale notice indicates potential share supply but is administrative in nature.

The form shows the distribution channel (Fidelity Brokerage Services) and labels the method as Cash. The presence of both the new proposed sale and the earlier sale provides a simple ledger of selling activity by holders associated with the issuer.

Market impact depends on execution size relative to float; the filing itself is procedural and does not alter capital structure or issuer proceeds.

Key Figures

Proposed shares to be sold: 53,336 shares Prior sale by holder: 160,009 shares Cash associated with proposed lot: $2,581,462.40 +1 more

4 metrics

Proposed shares to be sold 53,336 shares proposed sale via Fidelity on <date>05/15/2026</date>

Prior sale by holder 160,009 shares sale by Stephen Hoge on <date>02/23/2026</date>

Cash associated with proposed lot $2,581,462.40 line item linked to the 53,336 share entry

Cash from prior sale line $7,814,839.56 amount shown with Stephen Hoge's 160,009 share sale

Key Terms

Rule 144, Option Granted, Fidelity Brokerage Services

3 terms

Rule 144 regulatory

"filing a Rule 144 notice regarding the proposed sale"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Option Granted financial

"Option Granted 08/10/2016 appears next to securities line"

Fidelity Brokerage Services market

"Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	53336	2581462.40	396786259	05/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/15/2026	Option Granted 08/10/2016	Issuer			53336	05/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Stephen Hoge 325 Binney Street Cambridge MA 02142	Common	02/23/2026	160009	7814839.56

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the MRNA Rule 144 filing disclose about the proposed sale?

It discloses a proposed sale of 53,336 shares of Common Stock through Fidelity Brokerage Services on 05/15/2026. The filing lists a cash figure of $2,581,462.40 tied to that line item.

Who sold shares previously according to the excerpt for MRNA?

The excerpt records Stephen Hoge selling 160,009 shares on 02/23/2026, with a cash amount of $7,814,839.56 shown alongside that transaction line.

Does this Rule 144 filing mean Moderna receives proceeds from the sale?

The entries show sales by holders through a broker and list cash amounts; the filing does not state that the issuer will receive proceeds, so proceeds attribution is not specified in the excerpt.

How should investors interpret a Form 144 for MRNA?

Form 144 is a notice that restricted or control‑person shares may be sold under Rule 144; it documents planned or recent transactions but is procedural and does not by itself change the company’s outstanding share count.